Borderline Personality Disorder: 5 Questions About DBT and Medication

A diagnosis of borderline personality disorder, or BPD, can bring both relief and confusion. It may finally explain intense emotions, impulsive reactions, unstable relationships, or a painful fear of rejection. At the same time, treatment recommendations may raise new questions. Here are clear answers to five common questions about BPD treatment.

1. Is psychotherapy really more important than medication?

Yes. Structured psychotherapy is the main treatment for BPD. Dialectical behavior therapy, commonly known as DBT, is one of the most researched approaches.

However, this does not mean medication is always useless. Medication does not treat the personality disorder itself, but it may sometimes be prescribed for a specific symptom or a co-occurring condition, such as major depression or an anxiety disorder.

Medication should support psychotherapy rather than replace it. Its purpose, expected benefits, possible side effects, and planned duration should always be discussed with the prescribing clinician.

2. Is DBT the gold standard for BPD?

DBT is often described as a leading treatment because it was developed specifically for people who struggle with intense emotions, self-destructive behavior, and unstable relationships. Still, it is not the only effective psychotherapy for BPD.

The strength of DBT lies in its clear structure. It typically combines individual therapy with practical skills training. Patients learn how to:

• manage overwhelming emotions;
• tolerate distress without making the situation worse;
• communicate more effectively;
• become more aware of thoughts, emotions, and impulses.

Another important feature is the balance between acceptance and change. DBT teaches that a person can accept their current feelings while also working to change harmful patterns.

3. Why was I prescribed an antipsychotic if I do not have psychosis?

In the United States, the word antipsychotic is commonly used instead of neuroleptic. Although these medications were originally developed to treat psychotic disorders, clinicians sometimes prescribe them off-label for other specific symptoms.

In BPD treatment, a low dose may occasionally be considered for severe anger, impulsivity, intense agitation, or brief stress-related suspiciousness or unusual perceptual experiences. It may also be used for a separate condition diagnosed alongside BPD.

This does not automatically mean that the patient has psychosis. However, medication should have a clear target symptom and should be reviewed regularly. A person should not stop or change their dose without speaking to the prescriber.

4. Why is it so difficult to use DBT skills in real life?

Understanding a skill during therapy and applying it during an emotional crisis are very different things.

When emotions become intense, familiar reactions may appear faster than newly learned skills. This is not proof that therapy has failed or that the patient is doing something wrong. New responses require repetition.

After a difficult moment, it may help to ask:

• What triggered my reaction?
• What did I feel in my body?
• Which skill could I try next time?
• What support might help me use it earlier?

These situations can then be discussed openly with the therapist. Progress does not mean reacting perfectly every time. It means gradually noticing patterns sooner and making more deliberate choices.

5. How can I explain BPD to my family?

Loved ones may take emotional outbursts personally, especially when they do not understand what is happening.

A helpful first step is to share accurate information about BPD. With the patient’s permission, a family member may also attend an appointment so the clinician can explain the diagnosis and treatment.

Direct language can also reduce confusion:

“Sometimes my emotions become intense very quickly. My reaction may look as though I am angry with you, but I am often struggling to manage what is happening inside me. I am learning healthier ways to respond.”

BPD can explain certain reactions, but it does not remove personal responsibility. Honest conversations, clear boundaries, and consistent treatment can help both the individual and the family feel safer.

The Main Point

BPD is treatable. Psychotherapy is the foundation of treatment, while medication may have a limited, carefully defined supporting role. Learning new skills takes time, and temporary setbacks do not cancel progress.

Treatment works best when the patient, therapist, prescriber, and—when appropriate—family members understand the goals and communicate openly.

This article is for educational purposes and does not replace an individual assessment or treatment plan.

References

• American Psychiatric Association. (2024). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder. American Psychiatric Association Publishing. DOI: 10.1176/appi.books.9780890428009.
  • The guideline recommends a structured, evidence-supported psychotherapy. It states that medication should be time-limited, directed at a measurable symptom, and used only as an addition to psychotherapy. See the sections “Psychosocial Interventions” and “Pharmacotherapy.”
• Linehan, M. M., Comtois, K. A., Murray, A. M., et al. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy versus therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63(7), 757–766. DOI: 10.1001/archpsyc.63.7.757.
  • This randomized study compared DBT with treatment delivered by psychotherapy experts and evaluated suicidal behavior, treatment use, and outcomes during treatment and follow-up.
• Linehan, M. M., Korslund, K. E., Harned, M. S., et al. (2015). Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: A randomized clinical trial and component analysis. JAMA Psychiatry, 72(5), 475–482. DOI: 10.1001/jamapsychiatry.2014.3039.
  • This study examined the effectiveness of DBT and the contribution of its different treatment components for people with BPD at high risk of suicide.